HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO VISCERAL LEISHMANIASIS: CASE REPORT
DOI:
https://doi.org/10.56238/revgeov17n1-062Keywords:
Hemophagocytic Syndrome, Lymphohyostiocystosis, Kala-azar, Visceral LeishmaniasisAbstract
Introduction: Hemophagocytic Lymphohistiocytosis (HLH), or Hemophagocytic Syndrome (HHS), is a rare and serious condition caused by excessive activation of the immune system, manifesting as persistent fever, pancytopenia, and multisystem dysfunction. The secondary form, associated with infections and neoplasms, presents a diagnostic challenge in adults. The association of HLH with visceral leishmaniasis is uncommon and poorly described, requiring clinical reports. Objectives: To describe the clinical, laboratory, and diagnostic aspects of a case of HLH secondary to visceral leishmaniasis in an adult patient. Study design: This is a case report, which will be carried out through the analysis of medical records and results of hematological laboratory tests, as well as an interview with the patient. Therefore, secondary data sources will be used (medical records, radiographs, demographic data, and others). This is a 47-year-old male patient with systemic arterial hypertension and irregular medication use. The project will be registered on the Plataforma Brasil platform and submitted to the Research Ethics Committee (CEP) of the Centro Universitário de Caratinga - UNEC, which issued a favorable approval. The study will begin after CEP approval and will be conducted in accordance with the fundamental principles of Resolution 466/12 of the National Health Council (CNS), which deals with the Guidelines and Standards for Research Involving Human Beings. Those responsible for the research will commit to it through the Researcher Commitment Form. The information in this project and in the data collection will be kept confidential with the signing of the Informed Consent Form.
Downloads
References
HUANG, J.; PANG, W. S.; LOK, V.; ZHANG, L.; LUCERO-PRISNO, D. E., 3rd; XU, W.; ZHENG, Z. J.; ELCARTE, E.; WITHERS, M.; WONG, M. C. S.; NCD GLOBAL HEALTH RESEARCH GROUP, ASSOCIATION OF PACIFIC RIM UNIVERSITIES (APRU). Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. Journal of Hematology & Oncology, v. 15, n. 1, p. 57, 2022. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9097358/. Acesso em: 01 ago. 2025.
KONKOL, S.; KILLEEN, R. B.; RAI, M. Hemophagocytic lymphohistiocytosis. StatPearls. Treasure Island (FL): StatPearls Publishing, 2025. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK557776/. Acesso em: 24 jul. 2025.
LIMA, L. S.; OLIVEIRA NETO, C. P.; SILVA, I. M. C. Síndrome hematofagocítica e malignidade: uma relação pouco explorada. Research, Society and Development, v. 11, n. 5, 2022. Disponível em: https://rsdjournal.org/index.php/rsd/article/download/28139/24495/325771. Acesso em: 01 ago. 2025.
SANTOS, M. V.; BOM, A. P. K. P.; SILVA, A. S.; CORRADI, T. N.; CAMILLO, M. S.; BLEY, G. Síndrome hemofagocítica em vigência de infecção por Epstein-Barr vírus em criança de cinco anos: relato de caso. Brazilian Journal of Health Review, v. 8, n. 2, 2025. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/78353. Acesso em: 24 jul. 2025.
SOUZA, A. F.; PIZZOL, A. F.; LEITE, J. G.; RODRIGUES, J. B.; DRUMOND ARAÚJO, R.; TAVARES, Í. G. S.; SANTANA, M. T. O.; RODRIGUES, A. F.; VIEIRA, R. Y. R.; SILVA, Â. M. Síndrome hemofagocítica pós-leishmaniose visceral: revisão de literatura e relato de caso: Post-visceral leishmaniasis secondary hemophagocytic lymphohistiocytosis: case report and literature review. Brazilian Journal of Health Review, v. 5, n. 6, 2022. Disponível em: https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/55254. Acesso em: 01 ago. 2025.
TAVARES, Í. G. S.; SANTANA, M. T. O.; RODRIGUES, A. F.; VIEIRA, R. Y. R.; SILVA, Â. M. Leishmaniose visceral com síndrome hemofagocítica, abscesso e hematoma esplênico: um relato de caso. The Brazilian Journal of Infectious Diseases, v. 27, p. 103591, 2023. Disponível em: https://www.bjid.org.br/en-leishmaniose-visceral-com-sindrome-hemofagocitica-articulo-S1413867023008516. Acesso em: 01 ago. 2025.
WU, Y.; XU, S.; KANG, K.; YANG, Y. Q.; LI, E.; ZHAO, A.; NIU, T. Hemophagocytic lymphohistiocytosis: current treatment strategies and future directions. Journal of Hematology & Oncology, v. 17, n. 1, 2024. Disponível em: https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01621-x. Acesso em: 24 jul. 2025.